Skip to main content

Jeroen Werden

Analyst

TD Cowen

Equibles does not estimate personal net worth.

About Jeroen Werden

Jeroen Werden is recorded as Analyst at TD Cowen. Jeroen Werden has spoken on 1 earnings call across 1 company, most recently for Immunovant, Inc. on February 6, 2026. The companies whose calls Jeroen Werden spoke on are classified in the Healthcare sector.

Jeroen Werden on recent calls

“The IVIG is around $180, but the concomitant sort of price for VivGuard for these indications around $870 gross. So maybe help us understand how you're thinking about pricing of Brepo.”
Analyst — TD Cowen, Roivant 3Q 2025 Earnings Call ·

Affiliation history

  • TD Cowen

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity